Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Aortic Stenosis Market Over the Forecast Period of 2025 to 2034?
The market size for aortic stenosis has seen swift expansion in the past years. There’s a prediction for growth from $7.88 billion in 2024 to an estimated $8.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. This expansion during the historic phase can be linked to elements such as the aging demographic, heightened prevalence of associated risk factors, advancements in diagnostic technology, rising recognition of cardiac diseases, and enhanced healthcare infrastructure.
The size of the aortic stenosis market is projected to experience accelerated growth in the forthcoming years. It is set to expand to $14.54 billion by 2029, with a compound annual growth rate (CAGR) of 12.9%. The rise in the forecast period can be credited to an increased uptake of minimally invasive procedures, the growth of the elderly population, expanding healthcare spending, improved access to healthcare in emergent markets, and advancements in aortic valve replacement technology. Significant trends anticipated in the forecast period embrace robotic-assisted surgeries, 3D imaging and visualization, innovative developments in transcatheter aortic valve replacement (tavr), the application of artificial intelligence in diagnostics, and the use of biodegradable stents.
What Major Innovations Are Driving the Accelerated Growth of the Aortic Stenosis Market?
The rise in heart disease is projected to fuel the expansion of the aortic stenosis market in the future. Heart diseases are a broad set of conditions impacting the heart’s structure and functionality. These diseases can hinder the heart’s capacity to efficiently pump blood, causing complications. Some familiar heart diseases are coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy and others. Aortic stenosis pertains to the constriction of the aortic valve, impeding the blood flow from the left ventricle to the aorta. This heightens the resistance for the heart, obligating it to work harder and risking potential heart failure and cardiovascular complications over time. Appropriate interventions for aortic stenosis, such as valve replacement or TAVI, can enhance heart performance and lower the risk of severe heart disease consequences. According to the British Heart Foundation, a UK-based charity focused on cardiovascular research, it is projected that by January 2025, there will be about 7.6 million people in the UK suffering from heart and circulatory diseases, including roughly 4 million men and 3.6 million women. These diseases are responsible for approximately 27% of all the deaths in the UK, resulting in over 170,000 deaths annually or about 480 deaths every day. Therefore, the escalating incidences of heart diseases are contributing to the growth of the aortic stenosis market.
Request Your Free Aortic Stenosis Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp
Who are the key firms paving the way for growth in the Aortic Stenosis market?
Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave
What Key Trends Are Currently Impacting the Aortic Stenosis Market’s Development?
Leading businesses in the aortic stenosis industry are concentrating their efforts on the creation of cutting-edge aortic valve technologies like the transcatheter aortic valve implantation (TAVI) systems. These innovations are aimed at enhancing patient results, diminishing the dangers tied to the procedure, and upgrading the overall efficacy of the aortic treatment. The TAVI system, which is a less invasive substitute to open-heart surgery, can replace an ailing aortic valve. For example, in January 2023, the FDA gave approval to Abbott Laboratories, an American medical device firm, for their newest TAVI system called Navitor. This system uses the NaviSeal fabric cuff to decrease or even avoid paravalvular leaks. Additionally, the system is designed to place leaflets within the native valve, with the goal of enhancing access to coronary arteries for future treatments of coronary artery disease.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report
Which Segments Play a Crucial Role in the Expansion of the Aortic Stenosis Market?
The aortic stenosis market covered in this report is segmented –
1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis
2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty
3) By Administration: Oral, Parenteral, Implants
4) By Distribution Channel: Offline, Online
5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy
Subsegments:
1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis
2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis
Which Geographical Regions Are Pioneering Growth in the Aortic Stenosis Market?
North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Do Experts Define the Scope of the Aortic Stenosis Market?
Aortic stenosis is a condition where the aortic valve in the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is often caused by age-relate valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can lead to serious complications such as heart failure, which can be treated with medication or surgical interventions such as valve replacement.
Browse Through More Similar Reports By The Business Research Company:
Chronic Pain Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Late Stage Chronic Kidney Disease Drugs Global Market Report 2025
Chronic Lymphocytic Leukemia Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: